AHA, Others Urge HHS to Protect 340B Hospitals from Drug Companies Trying to Undermine Program

On behalf of the nation’s 340B hospitals, AHA, others urge the Department of Health and Human Services (HHS) to protect vulnerable communities from actions taken by five of the nation’s largest pharmaceutical manufacturers that undermine access to critical drugs and other health care services. We ask the HHS to use its authority to require that these and other pharmaceutical manufacturers comply with the law. This is particularly critical now as these hospitals need every resource available to care for their patients in vulnerable communities during the COVID-19 public health crisis.

Related Resources

Case Studies
Public
As of early October 2021, the health system reached a 99% vaccination rate among staff and more than 600,000 people were vaccinated throughout the region.
Other Resources
Public
New COVID-19 vaccine strategies to reach people still not vaccinated are under development.
Other Resources
Getting both viruses at once may lead to long-term damage or death.
Other Resources
CHOP’s online flu season resource center offers preventive measures, a look back at the history of the flu vaccine, “Just the Vax” trivia game and a fast facts…
Special Bulletin
Public
The Centers for Disease Control and Prevention (CDC) has released an initial document intended to assist jurisdictions across the country in planning for the…
Other Resources
Public
Getting the COVID-19 and flu vaccines is safe and effective and may ease strain on hospital staff.